Search

everythinglearnresearchcommunity

for

Search:↓

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

New understanding and treatments for hair loss are improving, but more research is needed.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Finasteride may cause kidney damage.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Erdr1 could be a new marker for diagnosing hair loss.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Changing Wnt signaling can lead to more or less hair growth and might help treat hair loss and skin conditions.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

A boy with toxic shock syndrome had severe heart rhythm problems but recovered with treatment.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

Sudden, unusual hair loss may indicate serious underlying health issues.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.